Prospective Acromegaly Cohort Study Established to Track Hormone Levels and Cardiovascular Risk Markers Post-Treatment

Acromegaly is a rare neuroendocrine disorder characterized by excessive growth hormone (GH) secretion, typically from a pituitary adenoma, leading to elevated insulin-like growth factor-1 (IGF-1). This chronic overproduction causes progressive somatic overgrowth, organomegaly, and significant comorbidities, including cardiovascular disease, diabetes mellitus, and arthropathy, substantially increasing morbidity and mortality. Current treatments aim to normalize GH and IGF-1 levels, often involving surgery, radiation, or somatostatin analogs like octreotide or GH receptor antagonists like pegvisomant. However, long-term outcomes and the precise impact on various disease markers and cardiovascular risk factors require ongoing, detailed prospective evaluation to optimize patient management and refine treatment targets.

This prospective, non-interventional observational study enrolled 311 patients with acromegaly at diagnosis to track hormone values and disease activity markers post-treatment. Patients were followed after receiving surgical or other therapies. The study aimed to determine blood levels of growth hormone and related hormones, including IGF-1, and cardiovascular risk markers, alongside signs and symptoms of the disease. A comparison group of 50 healthy subjects underwent a single oral glucose tolerance test (OGTT) to provide normative hormonal data. The study design focused on evaluating how these parameters change over time following various therapeutic interventions.

The provided abstract details the study's design and objectives but does not present any specific findings, results, or statistical data from the completed trial. Therefore, no quantitative outcomes, p-values, or fold-changes can be reported from this abstract. The study was designed to prospectively evaluate changes in hormone levels and disease markers in acromegaly patients after therapy, but the results of this evaluation are not included in the provided text.